[Skip to Content]
[Skip to Content Landing]
Article
May 1984

Experimental Ocular Herpetic Infections in RabbitsTreatment With 9-([2-Hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine

Author Affiliations

From the Departments of Microbiology (Dr Smith, Mss Hodges and Galloway, and Mr Kennell) and Ophthalmology (Dr Poirier), The University of Texas Health Science Center at San Antonio; and the Department of Chemistry, McGill University, Montreal (Dr Ogilvie and Mr Cheriyan).

Arch Ophthalmol. 1984;102(5):778-781. doi:10.1001/archopht.1984.01040030626036
Abstract

• A new acyclic nucleoside, 9-([2hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine (BIOLF-62), was found to be efficacious in the treatment of experimental ocular herpes simplex virus infections in rabbits. Complete healing of herpetic lesions occurred in a majority of animals after six days of topical treatment, three times per day. No toxic effects were observed in uninfected, drug-treated eyes. The BIOLF-62 treatment blocked viral replication in infected eyes sufficiently to make recovery of virus from any of the drug-treated eyes impossible, whereas virus was recovered from all placebo-treated eyes.

References
1.
Falcon MG, Jones BR:  Antiviral activity in the rabbit cornea of adenine arabinoside, ara-A 5′monophosphate, and hypoxanthine arabinoside; and interactions with adenosine deaminase inhibitor . J Gen Virol 1977;36:199-202.Article
2.
Puliafito CA, Robinson NL, Albert DM, et al:  Therapy of experimental herpes simplex keratitis in rabbits with 5-iodo-5′-amine-2′,5′-dideoxyuridine . Proc Soc Exp Biol Med 1977; 156:92-96.Article
3.
Kaufman HE:  Antimetabolite drug therapy in herpes simplex . Am Acad Ophthalmol 1980; 87:135-141.
4.
Pavan-Langston D, Campbell R, Lass J:  Acyclic antimetabolite therapy of experimental herpes simplex keratitis . Am J Ophthalmol 1978; 86:618-623.
5.
Kaufman HE, Varnell ED, Centifanto YM, et al:  Effect of 9-(2-hydroxy-ethoxymethyl)guanine on herpesvirus-induced keratitis and iritis in rabbits . Antimicrob Agents Chemother 1978; 14:842-845.Article
6.
Trousdale MD, Dunkel EC, Nesburn AB:  Effect of acyclovir on acute and latent herpes simplex virus infections in the rabbit . Invest Ophthalmol Vis Sci 1980;19:1336-1341.
7.
Jones BR, Coster DJ, Fison PN, et al:  Efficacy of acycloguanosine (Wellcome 248U) against herpes-simplex corneal ulcers . Lancet 1979; 1:243.Article
8.
Coster DJ, Wilhelmus KR, Michaud R, et al:  A comparison of acyclovir and idoxuridine as treatment for ulcerative herpetic keratitis . Br J Ophthalmol 1980;64:763-765.Article
9.
Collum LMT, Benedict-Smith A, Hillary IB:  Randomised double-blind trial of acyclovir and idoxuridine in dendritic corneal ulceration . Br J Ophthalmol 1980;64:766-769.Article
10.
Smith KO, Galloway KS, Kennell WL, et al:  A new nucleoside analogue, 9-[[2-hydroxy1-(hydroxymethyl) ethoxy] methyl] guanine, highly active in vitro against herpes simplex virus types 1 and 2 . Antimicrob Agents Chemother 1982;22:55-61.Article
11.
Elion GB, Furman PA, Fyfe JA, et al:  Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine . Proc Natl Acad Sci USA 1977;74:5716-5720.Article
12.
Furman PA, St. Clair MH, Fyfe JA, et al:  Inhibition of herpes simplex virus-induced DNA polymerase activity and viral DNA replication by 9-(2-hydroxy-ethoxymethyl) guanine and its triphosphate . J Virol 1979;32:72-77.
13.
Wander AH, Centifanto YM, Kaufman HE:  Strain specificity of clinical isolates of herpes simplex virus . Arch Ophthalmol 1980;98:1458-1461.Article
14.
Roizman B, Roane PR:  A physical difference between two strains of herpes simplex virus apparent on sedimentation in cesium chloride . Virology 1961;15:75-79.Article
15.
Ogilvie KK, Cheriyan UO, Radatus BK, et al:  Biologically active acyclonucleoside analogues: II. The synthesis of 9-[[2-hydroxy-1-(hydroxymethyl) ethoxy] methyl] guanine (BIOLF-62) . Can J Chem 1982;60;3005-3010.Article
16.
Jones BR, Al-Hussaini K:  Therapeutic consideration in ocular vaccinia . Trans Ophthalmol Soc UK 1963;83:613-631.
17.
Jones BR, Wise JB, Patterson A: Evaluation of Drug Effects on the Eye . London, F.J. Parsons Ltd, 1969, pp 83-98.
18.
Schnipper LE, Crumpacker CS:  Resistance of herpes simplex virus to acycloguanosine: Role of viral thymidine kinase and DNA polymerase loci . Proc Natl Acad Sci USA 1980;77:2270-2276.Article
19.
Sibrack CD, Gutman LT, Wilfert CM, et al:  Altered pathogenicity of acyclovir resistant HSV from an immune deficient child , abstracted. Pediatr Res 1981;15:621-631.Article
20.
Smith KO, Kennell WL, Poirier RH, et al:  In vitro and in vivo resistance of herpes simplex virus to 9-(2-hydroxyethoxymethyl)guanine (acycloguanosine) . Antimicrob Agents Chemother 1980;17:144-150.Article
21.
Crumpacker CS, Schnipper LE, Marlowe SI, et al:  Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir . N Engl J Med 1982;306:343-346.Article
22.
Smith KO, Galloway KS, Ogilvie KK, et al:  Synergism among BIOLF-62, phosphonoformate, and other antiherpetic compounds . Antimicrob Agents Chemother 1982;22:1026-1030.Article
×